Stepwise CaSR, AP2S1, and GNA11sequencing in patients with suspected familial hypocalciuric hypercalcemia

MLA

Szalat, Auryan, et al. “Stepwise CaSR, AP2S1, and GNA11sequencing in Patients with Suspected Familial Hypocalciuric Hypercalcemia.” Endocrine, vol. 55, no. 3, Mar. 2017, pp. 741–47. EBSCOhost, https://doi.org/10.1007/s12020-017-1241-5.

APA

Szalat, A., Shpitzen, S., Tsur, A., Zalmon Koren, I., Shilo, S., Tripto-Shkolnik, L., Durst, R., Leitersdorf, E., & Meiner, V. (2017). Stepwise CaSR, AP2S1, and GNA11sequencing in patients with suspected familial hypocalciuric hypercalcemia. Endocrine, 55(3), 741–747. https://doi.org/10.1007/s12020-017-1241-5

Chicago

Szalat, Auryan, Shoshana Shpitzen, Anat Tsur, Ilana Zalmon Koren, Shmuel Shilo, Liana Tripto-Shkolnik, Ronen Durst, Eran Leitersdorf, and Vardiella Meiner. 2017. “Stepwise CaSR, AP2S1, and GNA11sequencing in Patients with Suspected Familial Hypocalciuric Hypercalcemia.” Endocrine 55 (3): 741–47. doi:10.1007/s12020-017-1241-5.